Evaluation of a New Confirmatory Assay for Antibodies against Lymphadenopathy-Associated Virus (LAV)/Human T-Lymphotropic Virus Type III (HTLV III)
- 1 November 1986
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 51 (3) , 233-235
- https://doi.org/10.1111/j.1423-0410.1986.tb01960.x
Abstract
We have evaluated a newly developed competitive enzyme immunoassay for the specific detection of antibodies against LAV/HTLV III envelope and core proteins. Comparative studies of sera from high-risk donors showed complete concordance between the results of the confirmatory enzyme immunoassay and immunoblot or indirect immunofluorescence techniques. Studies of sera from blood donors with a repeatedly reactive screening test for anti-LAV/HTLV III demonstrated two specimens which were positive by the confirmatory enzyme immunoassay and negative or indeterminable by immunoblotting and immunofluorescence.This publication has 5 references indexed in Scilit:
- WHICH ANTI-HTLV III/LAV ASSAYS FOR SCREENING AND CONFIRMATORY TESTING?The Lancet, 1985
- HLA ANTIBODIES DETECTED BY ELISA HTLV-III ANTIBODY KITSThe Lancet, 1985
- HLA DR4 ANTIBODIES CAUSE POSITIVE HTLV-III ANTIBODY ELISA RESULTSThe Lancet, 1985
- Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirusNature, 1985
- INCREASE IN PREVALENCE OF ANTI-HTLV-III IN HAEMOPHILIACSThe Lancet, 1984